Lary A Robinson
Overview
Explore the profile of Lary A Robinson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
682
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dravillas C, Coleman 4th S, Hoyd R, Caryotakis G, Denko L, Chan C, et al.
Cancer Res Commun
. 2024 Jul;
4(8):1978-1990.
PMID: 39015091
Significance: We analyzed the tumor microbiome and interactions with genes and pathways in metastatic melanoma treated with immunotherapy and identified several microbes associated with immunotherapy response and immune-related gene expression...
2.
Robinson L, Tanvetyanon T, Robinson N, Bryant S, Bailey A, Reed D, et al.
Clin Lung Cancer
. 2024 Jun;
25(6):537-549.e2.
PMID: 38926078
Objectives: Small-cell lung carcinoma (SCLC) is usually a wide-spread, highly-lethal malignancy but occasionally presents as localized, limited stage cancer amenable to local treatment. We reviewed our experience using surgery or...
3.
Benej M, Hoyd R, Kreamer M, Wheeler C, Grencewicz D, Choueiry F, et al.
Cancer Res Commun
. 2024 Jun;
4(7):1690-1701.
PMID: 38904265
Significance: Tumor hypoxia reduces radiotherapy efficacy. In this study, we explored whether some of the clinical effects of hypoxia could be due to interaction with the tumor microbiome. Hypoxic gene...
4.
Zhang Y, Darville L, Hogue S, Hallanger Johnson J, Rose T, Kim Y, et al.
Cancers (Basel)
. 2024 Mar;
16(6).
PMID: 38539486
Sex difference in the immune response may influence patients' response to immune checkpoint inhibitors (ICIs). We conducted a prospective observation study to determine the correlation between pretreatment sex hormone levels...
5.
Wang C, Ma A, Li Y, McNutt M, Zhang S, Zhu J, et al.
Cancer Res Commun
. 2024 Jan;
4(2):293-302.
PMID: 38259095
Significance: Studying the tumor microbiome in high-throughput sequencing data is challenging because of the extremely sparse data matrices, heterogeneity, and high likelihood of contamination. We present a new deep learning...
6.
Wang C, Ma A, McNutt M, Hoyd R, Wheeler C, Robinson L, et al.
bioRxiv
. 2023 Jun;
PMID: 37292990
Evidence supports significant interactions among microbes, immune cells, and tumor cells in at least 10-20% of human cancers, emphasizing the importance of further investigating these complex relationships. However, the implications...
7.
Wheeler C, Coleman 4th S, Hoyd R, Denko L, Chan C, Churchman M, et al.
bioRxiv
. 2023 Jun;
PMID: 37292921
Emerging evidence supports the important role of the tumor microbiome in oncogenesis, cancer immune phenotype, cancer progression, and treatment outcomes in many malignancies. In this study, we investigated the metastatic...
8.
Abdelghany K, Robinson L, Tanvetyanon T
Cureus
. 2022 Nov;
14(10):e30364.
PMID: 36407249
Background Adjuvant chemotherapy can further improve treatment outcomes following the resection of non-small cell lung cancer (NSCLC). However, in practice, some patients are unable to tolerate all prescribed chemotherapy. One...
9.
Zhang Y, Seminario-Vidal L, Cohen L, Hussaini M, Yao J, Rutenberg D, et al.
Front Cell Infect Microbiol
. 2022 Jun;
12:850509.
PMID: 35656034
Cutaneous T cell lymphoma (CTCL), a non-Hodgkin lymphoma, is thought to arise from mature tissue-resident memory T cells. The most common subtypes include Mycosis Fungoides and Sezary Syndrome. The role...
10.
Newsome R, Gharaibeh R, Pierce C, da Silva W, Paul S, Hogue S, et al.
Genome Med
. 2022 Mar;
14(1):35.
PMID: 35346337
Background: Recent studies show that human gut microbial composition can determine whether a patient is a responder or non-responder to immunotherapy but have not identified a common microbial signal shared...